Objective To describe hepatotoxicity due to amiodarone and dronedarone from the DILIN
and the US FDA's surveillance database. Methods Hepatotoxicity due to amiodarone and …

Background: The prevalence of hepatotoxicity after longterm oral amiodarone therapy in
Chinese patients with or without elevated liver enzymes at baseline is unknown. Hypothesis …

This cross-sectional, retrospective study was designed to evaluate the current clinical
applications and acute hepatotoxicity of intravenous amiodarone administration at a hospital …

Amiodarone has been reported to cause asymptomatic increases in liver function tests in 15—
55% of patients. Clinically apparent, symptomatic hepatic disease occurs less frequently, but …

Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding
whether to initiate or continue treatment with this medication. While mostly associated with …

Amiodarone is a class III antiarrhythmic drug used to treat several tachyarrhythmias.
Although toxicity by long-term oral therapy is known, it is rare to observe the acute toxicity …

Amiodarone, a commonly used antiarrhythmic agent, has numerous adverse effects. The
purpose of this case report is to highlight its hepatotoxicity, an unusual complication of long …

Amiodarone, is a widely used class III antiarrhythmic agent with a T1/2 (half-life) expectancy

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Objectives Amiodarone is widely used to treat arrhythmia. However, amiodarone is known
for its severe toxicity to the liver, lungs, and thyroid. Amiodarone causes liver damage …